Iovate Initiates Voluntary Recall Of Hydroxycut Products After FDA Warning
May 5, 2009
After learning that the U.S. Food and Drug Administration’s warning about Hydroxycut related products, Iovate initiated a voluntary recall. The FDA assessed 23 reports of personal injury from Hydroxycut related products including consumers who experienced liver-related injury. Iovate claims that the research is different from their own analysis. On May 1, 2009, the FDA issued an advisory which states that, “Although the liver damage appears to be relatively rare, FDA believes consumers should not be exposed to unnecessary risk.” Iovate’s own assessment of the potential risk associated with the use of these products differs from that expressed by the FDA. Iovate says, "However, out of an abundance of caution and because consumer safety is Iovate’s top priority, Iovate is voluntarily recalling these Hydroxycut-branded products."
Many of the symptoms may not be know to be related to the Hydroxycut product. If you believe you started experiencing symptoms soon after taking the Hydroyxcut related products please fill out a free case evaluation.
- Asbestos
- Class Actions
- Commercial Litigation
- Defective Products
- Drug Injury
- Personal Injury
- Securities Fraud
- Toxic Exposure
- Accutane Side Effects
- Darvon and Darvocet
- DePuy Hip Recall
- Fosamax Femur Fractures
- Muscle Injury
- Sleeping Pill Dangers
- SSRI Birth Defects
- Topamax Birth Defects
- Transvaginal Surgical Mesh and Bladder Slings
- Tylenol Liver Damage
- Zocor/Simvastatin
Pending Settlements
